Nicholas Haft
InvestorManaging Director at OMX Ventures
New York, New York
Writes $500K – $15M checks · typically $7.8M
About
Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- OMX VenturesManaging Directorcurrent2020 — presentNew York, New York, United States
- Delix TherapeuticsCo-Foundercurrent2019 — presentNew York, United States
- Arcos VenturesManaging Director2014 — 2020New York, United States
Investments
Investor
10X GenomicsCompass PathwaysFinch TherapeuticsGinkgo BioworksImagenPendulum Therapeutics
Per the firm's website.
Colleagues at OMX Ventures
Craig Asher
Managing Director at OMX Ventures
Daniel Fero
Managing Director at OMX Ventures
Fred Sweeney
Venture Partner at OMX Ventures
John Nawrocki
Chief Financial Officer at OMX Ventures
Natasha Azar
Vice President Investor Relations at OMX Ventures
Paul Conley
Chairman & CEO at GENERAL INCEPTION
Swetha Murali
Vice President at OMX Ventures
Tim Richardson
Strategic Advisor at GENERAL INCEPTION
Network1
Investors connected to Nicholas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Nicholas Haft?
- Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.
- Where does Nicholas Haft work?
- Nicholas Haft is Managing Director at OMX Ventures.
- What does Nicholas Haft invest in?
- Nicholas Haft invests in Biotech.
- What check size does Nicholas Haft write?
- Nicholas Haft typically writes checks of $500K – $15M.
- What companies has Nicholas Haft invested in?
- Investments tracked here include 10X Genomics, Compass Pathways, Finch Therapeutics, Ginkgo Bioworks, Imagen, Pendulum Therapeutics.
- Where did Nicholas Haft go to school?
- Nicholas Haft studied at The Wharton School.
Same school
Also attended The Wharton School1,984
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,978 more
